10-QNAUTCIK 0001808805

Nautilus Biotechnology, Inc.

Name: SEC EDGAR filing 0001808805-26-000052
Creator: Nautilus Biotechnology, Inc.
License: https://www.usa.gov/government-works

Quarterly report (10-Q) filed October 27, 2026.

Unaudited quarterly financial report filed by U.S. public companies for the first three fiscal quarters.

Open the filing on SEC.gov

New to the 10-Q? What it is and how to read one

Filing facts

Accession number: 0001808805-26-000052
Filer: Nautilus Biotechnology, Inc.
Ticker: NAUT
CIK: 0001808805
Form type: 10-Q
Form description: Quarterly report
Filed at: October 27, 2026
Industry: SIC 3826Laboratory Analytical Instruments
Last verified: October 27, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Nautilus Biotechnology, Inc.

8-KMaterial eventSep 11, 2026

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1808805/000180880526000052/0001808805-26-000052-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Nautilus Biotechnology, Inc. (0001808805) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001808805-26-000052.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.